
Opinion|Videos|January 7, 2025
Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care
Panelists discuss the key challenges faced by patients with diffuse large B-cell lymphoma and follicular lymphoma at diagnosis, how these challenges evolve during treatment, and the emotional and psychological support strategies employed to help patients navigate their lymphoma journey.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the key challenges that patients with diffuse large B-cell lymphoma (DLBCL) face at the time of diagnosis, and how do these challenges evolve throughout treatment?
- Can you discuss the same for patients with follicular lymphoma (FL)?
- How do you approach addressing the emotional and psychological challenges that patients with DLBCL and FL face, particularly when they first receive their diagnosis?
- What are the most important factors in helping patients navigate their journey with DLBCL or FL?
Advertisement
Related to this article

Real-world acne treatment adherence spans 6% to 84%, with cost, adverse effects, and slow results driving nonadherence.

A value-based care pilot within Kentucky’s Medicaid program reduced total costs for adults with substance use disorder while improving utilization of evidence-based treatments.

A scalable, symptom-focused patient education model paired with coordinated podiatric care offers managed care organizations a low-barrier strategy to reduce diabetic foot ulcers and costly amputations.

Pimicotinib, a once-daily oral CSF-1R inhibitor, is now FDA approved for adults with TGCT for whom surgery may worsen function or cause severe morbidity.

Pooled real-world data show an 88% response rate with brexu-cel in relapsed mantle cell lymphoma (MCL), but cost and QOL data are scarce.

Employer diabetes guide; Camden psychedelic therapy input; CRC after EMR; rural HFrEF care; JAMA obesity report.

This article analyzes gaps in US biosimilar development, quantifies market opportunities, and proposes policy and economic solutions to improve cost savings and patient access.
Advertisement
Advertisement

